GAMBRO RENAL PRODUCTS
- Baxter Appoints Munib Islam to Board; Announces Agreement with Third Point Business Wire Health News
- Generics Maker Can't Duck Baxter Suit Over Brevibloc Law 360 Intellectual Property
- Baxalta opens $14 million Bioscience Training Center The Morgan County Citizen - Features - Madison, GA
- Baxalta to outsource biosimilar production, will sell Minn. plant Biotechnology Industry Organization BIO SmartBrief
- Shire Weighing Options to Sweeten All-Stock Offer for Baxalta Wall Street Journal - Markets
- Georgia opens bioscience tranining center Bizjournals Health Care
- Word is the Ariad-Baxalta deal is dead. Here's what we learned. The Boston Business Journal - Local News - Boston, MA
- Buzz: Baxalta hunts for a buyout after rejecting Shire offer Fierce Biotech News
- Deals Rumor Mill: Baxalta, Worldpay, Qihoo 360 Law 360 Technology
- Baxter and Water Street Announce FDA Approval of CEFAZOLIN 2 Gram Premix Business Wire Health News
Alerts on more than 5,000 companies today, including:
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on GAMBRO RENAL PRODUCTS
- Rate GAMBRO RENAL PRODUCTS on their payment behavior
- Ask your network about GAMBRO RENAL PRODUCTS with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.